Menaquinone-4 (MK-4)

Category
vitamin
Routes
Oral (PO)
Half-Life (t½)
PO: 1h
Formula
C31H40O2
Molecular Weight
444.65 g/mol
PubChem CID
5282367
Aliases
Vitamin K2 MK-4, Menatetrenone

Pharmacological Mechanism

Carboxylates extrahepatic Gla proteins — matrix Gla protein (inhibits vascular calcification), osteocalcin (binds bone Ca²⁺), Gas6 (axon regeneration). Short (4-isoprenoid) side chain gives MK-4 a shorter plasma t½ (~1 h) than MK-7 but higher tissue turnover. Extrahepatically synthesised from K1 via side-chain conversion — dietary MK-4 supplements the tissue pool directly.

Half-Life & Elimination Curve (PO: 1h)

100%50%25%12.5%0%0h0×t½1h1×t½2h2×t½3h3×t½4h4×t½5h5×t½0×t½ (0h): 100% remaining (~0.208 µg/L)1×t½ (1h): 50% remaining (~0.104 µg/L)2×t½ (2h): 25% remaining (~0.0519 µg/L)3×t½ (3h): 12.5% remaining (~0.0259 µg/L)4×t½ (4h): 6.3% remaining (~0.013 µg/L)5×t½ (5h): 3.1% remaining (~0.00649 µg/L)
Plasma (PO)t½ Decay (1h)
  • 0×t½0h100% (0.208 µg/L)
  • 1×t½1h50% (0.104 µg/L)
  • 2×t½2h25% (0.0519 µg/L)
  • 3×t½3h12.5% (0.0259 µg/L)
  • 4×t½4h6.3% (0.013 µg/L)
  • 5×t½5h3.1% (0.00649 µg/L)
Elimination t½1h (PO)
Rate Constant (ke)0.693 h⁻¹
Time to Peak (Tmax)1.19h
Est. Peak (Cmax)0.208 µg/L
Clearance (CL)9.7 L/h
97% Washout (5×t½)5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References